10 Years of Answers, Together

Back to ListBack to List

“10 Years of Answers, Together” 3billion Celebrates 10th Anniversary

News | 26. 10. 07

“10 Years of Answers, Together”
3billion Celebrates 10th Anniversary

  • More than 100,000 patients tested across 75+ countries
  • 10 stories highlight a decade of progress in rare disease diagnosis
  • 3billion extends its capabilities from diagnosis to early detection and therapeutics

SEOUL, South Korea — 3billion, an AI-powered rare disease genetic diagnostics company, announced that it has launched “10 Years of Answers, Together,” a campaign marking its 10th anniversary, reflecting on the past decade, and sharing its vision for the future.

The campaign aims to express gratitude to the patients and families, healthcare professionals, researchers, and partners who have joined 3billion in the search for answers to rare diseases, while reaffirming the company’s mission to help more patients find answers and sharing its vision for the future.

The 10th anniversary website is available through 3billion’s official website. Throughout the campaign, 3billion will release a series of online content featuring patients, healthcare professionals, partners, and team members, along with highlights from the past decade, showcasing the journey of finding answers to rare diseases together.

Founded in 2016, 3billion has developed AI-powered genetic variant interpretation technology to help rare disease patients receive an accurate diagnosis more quickly, reducing the long and complex “diagnostic odyssey” that often involves visits to multiple medical institutions. Over the past decade, the company has delivered test results to more than 100,000 patients, and today more than 2,200 healthcare professionals across 75+ countries use 3billion’s testing services. Revenue more than doubled in each of the past three years, reaching KRW 11.7 billion in 2025.

The 10th anniversary website also highlights key milestones from the company’s genomic analysis over the past decade. To date, 3billion has analyzed approximately 3.287 trillion DNA base pairs—an amount that, if laid end to end, would circle the Earth about 28 times. The company’s servers hold 4,200 TB of genomic data, while 48,798 genetic variants have been reported to patients. These figures are visualized on the 10th anniversary website to illustrate the scale of the company’s genomic analysis over the past decade.

The campaign will also feature 10 stories highlighting the people and experiences behind 3billion’s decade-long journey in rare disease diagnostics. The series will trace the challenges the company set out to address, the process of translating its technology into clinical services, the experiences of patients and families who finally identified the cause of their condition after a long diagnostic journey, and the efforts of healthcare professionals, partners, and team members in Korea and abroad who have helped advance rare disease diagnosis. Together, these stories will reflect the diverse experiences that have shaped 3billion’s journey and the changes made possible over the past decade.

Changwon Keum, CEO of 3billion, said, “Delivering test results to more than 100,000 patients has been made possible by the healthcare professionals who have worked tirelessly to uncover the causes of disease, the patients and families who have waited for answers, and the partners and team members who have supported us along the way. We will continue to bring answers to more patients and families around the world, while expanding new possibilities from diagnosis to therapeutic development to help transform the lives of people with rare diseases.”

During the campaign, visitors can explore the anniversary content and leave messages of support on the 10th anniversary website. For each message posted, 3billion will contribute one hour of employee volunteer service, extending the trust and support it has received over the years into giving back to the community.

Get exclusive rare disease updates
from 3billion.

3billion Inc.

3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.

Read More from This Author

Recommended For You